Soligenix Inc.'s CEO Christopher Schaber Interviewed by The

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Soligenix Inc.'s CEO Christopher Schaber Interviewed by The Life Sciences Report

SAN FRANCISCO, CA--(Marketwired - Apr 9, 2015) - Orphan diseases associated with inflammation present excellent development opportunities for small biopharmaceutical companies and their investors. Additionally, inflammatory conditions can result from treatment with cancer therapeutics. The crossover between inflammation and oncology, coupled with vaccine programs of high strategic value, have allowed Soligenix Inc. ( OTCQB : SNGX ) to build a significant pipeline with substantial revenue potential. In this interview with The Life Sciences Report , Dr. Christopher J. Schaber, company President and CEO, outlines development programs targeting pediatric Crohn's disease, GI acute radiation syndrome, a rare lymphoma and the threat of ricin.

The Life Sciences Report: Soligenix Inc. has a broad technology base covering inflammation, oncology and biodefense. From a development perspective, how do you prioritize these target areas?

Christopher Schaber: We structure our pipeline to individual development teams, so that all programs are priorities. However, as you would imagine, the development phase and timing to critical data play an important role in program prioritization.

We have two U.S. Food and Drug Administration (FDA) fast-tracked, Phase 3, pivotal trials that are set to begin in 2015, one in pediatric Crohn's disease and the other in cutaneous T-cell lymphoma (CTCL), both orphan indications. In addition, we have a Phase 2 fast-tracked trial in oral mucositis in head-and-neck cancer. We expect data from this trial in mid-2015. Due to their development status, these inflammation and oncology programs are high priorities for 2015...

Continue reading this interview with Christopher Schaber: Soligenix Takes the Fast Track to Beat Inflammation, Cancer and Bio-Threats

About Streetwise Reports - The Life Sciences Report Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that will help you capitalize on these developing trends.

DISCLOSURE: Soligenix Inc. paid The Life Sciences Report to conduct, produce and distribute the interview. Christopher Schaber had final approval of the content and is wholly responsible for the validity of the statements. Opinions expressed are the opinions of Christopher Schaber and not of The Life Sciences Report or its officers.

Brandon Fung Tel: 707-981-8107 Email: Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating the Pioneers: Results of the 2025 Belonging Awards

Updated Category News Views 242

Introduction to the 2025 Belonging Awards The 2025 Belonging Awards stand as a testament to organizations dedicated to fostering an inclusive workplace. This year, the awards, organized by the Employer Branding Institute, saw a remarkable competition among companies globally, showcasing their commitment to Diversity, Equity, and Inclusion (DEI). The extensive evaluation...

Continue Reading
AI Innovations Driving Growth in Hypothyroidism Market

Updated Category News Views 183

The Growing Hypothyroidism Market and Its Innovations The global hypothyroidism market is on the brink of significant expansion, with projections indicating a remarkable growth of USD 789.8 million over the upcoming years. This growth is fueled by innovative advancements and strategic approaches within the healthcare sector. The market is expected to exhibit an impressive...

Continue Reading
Richmond Heights Celebrates 75 Years with Inspiring Stories

Updated Category News Views 273

Celebating 75 Years of Richmond Heights The Richmond Heights community recently came together for a significant milestone, marking 75 years of rich history and cultural diversity. The celebration was not only about the past; it was a heartfelt acknowledgment of the leaders who have molded this extraordinary place over decades. A Tribute to Community Leaders This special...

Continue Reading
Investigation Launched into Dyne Therapeutics Over Stock Drop

Updated Category News Views 82

Investigation Launched into Dyne Therapeutics Following Stock Decline Dyne Therapeutics, Inc. (NASDAQ: DYN), recognized for its groundbreaking approaches to treating muscular dystrophy, is currently facing scrutiny as Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential claims on behalf of investors. This action follows some concerning news...

Continue Reading
Taseko Mines: Highlights from Q1 Earnings Report and Future Plans

Updated Category News Views 211

Insight into Taseko Mines Limited's Q1 2025 Performance Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO), based in Vancouver, British Columbia, is making waves in the mining sector with its compelling first quarter earnings report for 2025. The company disclosed an Adjusted EBITDA of $34 million and earnings from mining operations before depletion and...

Continue Reading